The rheolytic thrombectomy market size has grown rapidly in recent years. It will grow from $1.14 billion in 2025 to $1.26 billion in 2026 at a compound annual growth rate (CAGR) of 10.6%. The growth in the historic period can be attributed to increasing occurrence of thrombotic disorders, rising burden of cardiovascular diseases, increasing uptake of minimally invasive procedures, progress in interventional vascular technologies, greater availability of specialized vascular care centers.
The rheolytic thrombectomy market size is expected to see rapid growth in the next few years. It will grow to $1.9 billion in 2030 at a compound annual growth rate (CAGR) of 10.9%. The forecast period growth can be attributed to the increasing prevalence of deep vein thrombosis and pulmonary embolism, rising need for fast clot extraction procedures, advancements in thrombectomy device technologies, growing investments in healthcare infrastructure, and expanding use of image-guided vascular interventions. Key trends during the forecast period include improvements in catheter-based clot removal systems, rising preference for minimally invasive thrombectomy techniques, development of high-efficiency saline jet mechanisms, wider adoption of rapid blood flow restoration methods, and increased application of thrombectomy in peripheral vascular procedures.
The rising prevalence of cardiovascular diseases is expected to propel the growth of the rheolytic thrombectomy market going forward. Cardiovascular diseases (CVDs) refer to a group of disorders affecting the heart and blood vessels, including conditions such as coronary artery disease, stroke, heart failure, and hypertension. The rising prevalence of cardiovascular diseases is primarily due to unhealthy lifestyles, which negatively affect heart health and increase the risk of developing heart-related disorders. Rheolytic thrombectomy contributes to the management of cardiovascular diseases by rapidly dissolving and removing blood clots from occluded vessels using high-velocity saline jets and suction, thereby restoring normal blood flow, reducing ischemic damage, and improving patient outcomes in acute thrombotic conditions. For instance, in March 2025, according to the Joint Strategic Needs Assessment, a UK-based community health center, the number of deaths caused by cardiovascular disease (CVD) was 185 in 2023, compared to 178 recorded in 2022. Therefore, the increasing prevalence of cardiovascular diseases is driving the growth of the rheolytic thrombectomy market.
The rising burden of thrombotic conditions is expected to propel the growth of the rheolytic thrombectomy market going forward. Thrombotic disorders refer to medical conditions in which abnormal blood clots form inside blood vessels, disrupting normal blood flow. The burden of thrombotic conditions is growing due to an aging population, as older individuals are more prone to reduced blood flow, vascular damage, and underlying conditions that increase the risk of abnormal blood clot. Rheolytic thrombectomy enhances the management of thrombotic conditions by rapidly fragmenting and aspirating blood clots to restore vessel patency and improve downstream blood flow in acute vascular occlusions. For instance, in December 2025, according to the National Health Service (NHS) England, a UK-based government department, venous thromboembolism (VTE) risk assessment coverage in England reached 92% in Quarter 3 (October to December 2025) of 2025/26, with 3.4 million out of 3.7 million admitted patients being assessed on admission. Therefore, the rising prevalence of thrombotic disorders is driving the growth of the rheolytic thrombectomy market.
The increasing aging population is expected to propel the growth of the rheolytic thrombectomy market going forward. An aging population refers to a demographic structure in which the proportion of elderly individuals is higher than the proportion of younger individuals. The increasing aging population is primarily driven by rising life expectancy, as people are living longer and more individuals are reaching older age groups. Rheolytic thrombectomy enables rapid mechanical and pharmacochemical removal of blood clots to restore vascular flow, addressing the growing burden of age-related thrombotic disorders in the aging population. For instance, in February 2025, according to the World Health Organization, a Switzerland-based intergovernmental organization, the number of people aged 60 years and older worldwide is projected to increase from 1.1 billion in 2023 to 1.4 billion by 2030. Therefore, the increasing aging population is driving the growth of the rheolytic thrombectomy market.
Major companies operating in the rheolytic thrombectomy market are Johnson & Johnson, Abbott Laboratories, Medtronic plc, Koninklijke Philips N.V., Stryker Corporation, Becton Dickinson and Company, Boston Scientific Corporation, Terumo Corporation, Edwards Lifesciences, Teleflex Incorporated, Penumbra Inc., Inari Medical Inc., AngioDynamics Inc., Surmodics Inc., LeMaitre Vascular Inc., Imperative Care Inc., Argon Medical Devices Inc., Acandis GmbH & Co. KG, Vesalio LLC.
North America was the dominant region in the rheolytic thrombectomy market in 2025. Asia-Pacific is expected to be the rapidly expanding region in the forecast period. The regions covered in rheolytic thrombectomy report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the rheolytic thrombectomy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The rheolytic thrombectomy market consists of revenues earned by entities by providing services such as catheter-based clot removal, emergency thrombectomy procedures, treatment of deep vein thrombosis and pulmonary embolism, peripheral arterial clot extraction, and post-procedure vascular care. The market value includes the value of related goods sold by the service provider or included within the service offering. The rheolytic thrombectomy market also includes sales of thrombectomy console systems, pump and power pulse delivery systems, aspiration and collection systems, and accessory kits and disposables. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
The rheolytic thrombectomy market research report is one of a series of new reports that provides rheolytic thrombectomy market statistics, including rheolytic thrombectomy industry global market size, regional shares, competitors with a rheolytic thrombectomy market share, detailed rheolytic thrombectomy market segments, market trends and opportunities, and any further data you may need to thrive in the rheolytic thrombectomy industry. This rheolytic thrombectomy market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
This product will be delivered within 1-3 business days.
The rheolytic thrombectomy market size is expected to see rapid growth in the next few years. It will grow to $1.9 billion in 2030 at a compound annual growth rate (CAGR) of 10.9%. The forecast period growth can be attributed to the increasing prevalence of deep vein thrombosis and pulmonary embolism, rising need for fast clot extraction procedures, advancements in thrombectomy device technologies, growing investments in healthcare infrastructure, and expanding use of image-guided vascular interventions. Key trends during the forecast period include improvements in catheter-based clot removal systems, rising preference for minimally invasive thrombectomy techniques, development of high-efficiency saline jet mechanisms, wider adoption of rapid blood flow restoration methods, and increased application of thrombectomy in peripheral vascular procedures.
The rising prevalence of cardiovascular diseases is expected to propel the growth of the rheolytic thrombectomy market going forward. Cardiovascular diseases (CVDs) refer to a group of disorders affecting the heart and blood vessels, including conditions such as coronary artery disease, stroke, heart failure, and hypertension. The rising prevalence of cardiovascular diseases is primarily due to unhealthy lifestyles, which negatively affect heart health and increase the risk of developing heart-related disorders. Rheolytic thrombectomy contributes to the management of cardiovascular diseases by rapidly dissolving and removing blood clots from occluded vessels using high-velocity saline jets and suction, thereby restoring normal blood flow, reducing ischemic damage, and improving patient outcomes in acute thrombotic conditions. For instance, in March 2025, according to the Joint Strategic Needs Assessment, a UK-based community health center, the number of deaths caused by cardiovascular disease (CVD) was 185 in 2023, compared to 178 recorded in 2022. Therefore, the increasing prevalence of cardiovascular diseases is driving the growth of the rheolytic thrombectomy market.
The rising burden of thrombotic conditions is expected to propel the growth of the rheolytic thrombectomy market going forward. Thrombotic disorders refer to medical conditions in which abnormal blood clots form inside blood vessels, disrupting normal blood flow. The burden of thrombotic conditions is growing due to an aging population, as older individuals are more prone to reduced blood flow, vascular damage, and underlying conditions that increase the risk of abnormal blood clot. Rheolytic thrombectomy enhances the management of thrombotic conditions by rapidly fragmenting and aspirating blood clots to restore vessel patency and improve downstream blood flow in acute vascular occlusions. For instance, in December 2025, according to the National Health Service (NHS) England, a UK-based government department, venous thromboembolism (VTE) risk assessment coverage in England reached 92% in Quarter 3 (October to December 2025) of 2025/26, with 3.4 million out of 3.7 million admitted patients being assessed on admission. Therefore, the rising prevalence of thrombotic disorders is driving the growth of the rheolytic thrombectomy market.
The increasing aging population is expected to propel the growth of the rheolytic thrombectomy market going forward. An aging population refers to a demographic structure in which the proportion of elderly individuals is higher than the proportion of younger individuals. The increasing aging population is primarily driven by rising life expectancy, as people are living longer and more individuals are reaching older age groups. Rheolytic thrombectomy enables rapid mechanical and pharmacochemical removal of blood clots to restore vascular flow, addressing the growing burden of age-related thrombotic disorders in the aging population. For instance, in February 2025, according to the World Health Organization, a Switzerland-based intergovernmental organization, the number of people aged 60 years and older worldwide is projected to increase from 1.1 billion in 2023 to 1.4 billion by 2030. Therefore, the increasing aging population is driving the growth of the rheolytic thrombectomy market.
Major companies operating in the rheolytic thrombectomy market are Johnson & Johnson, Abbott Laboratories, Medtronic plc, Koninklijke Philips N.V., Stryker Corporation, Becton Dickinson and Company, Boston Scientific Corporation, Terumo Corporation, Edwards Lifesciences, Teleflex Incorporated, Penumbra Inc., Inari Medical Inc., AngioDynamics Inc., Surmodics Inc., LeMaitre Vascular Inc., Imperative Care Inc., Argon Medical Devices Inc., Acandis GmbH & Co. KG, Vesalio LLC.
North America was the dominant region in the rheolytic thrombectomy market in 2025. Asia-Pacific is expected to be the rapidly expanding region in the forecast period. The regions covered in rheolytic thrombectomy report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the rheolytic thrombectomy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The rheolytic thrombectomy market consists of revenues earned by entities by providing services such as catheter-based clot removal, emergency thrombectomy procedures, treatment of deep vein thrombosis and pulmonary embolism, peripheral arterial clot extraction, and post-procedure vascular care. The market value includes the value of related goods sold by the service provider or included within the service offering. The rheolytic thrombectomy market also includes sales of thrombectomy console systems, pump and power pulse delivery systems, aspiration and collection systems, and accessory kits and disposables. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
The rheolytic thrombectomy market research report is one of a series of new reports that provides rheolytic thrombectomy market statistics, including rheolytic thrombectomy industry global market size, regional shares, competitors with a rheolytic thrombectomy market share, detailed rheolytic thrombectomy market segments, market trends and opportunities, and any further data you may need to thrive in the rheolytic thrombectomy industry. This rheolytic thrombectomy market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Rheolytic Thrombectomy Market Characteristics
3. Rheolytic Thrombectomy Market Supply Chain Analysis
4. Global Rheolytic Thrombectomy Market Trends And Strategies
5. Rheolytic Thrombectomy Market Analysis Of End Use Industries
7. Global Rheolytic Thrombectomy Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis
8. Global Rheolytic Thrombectomy Total Addressable Market (TAM) Analysis for the Market
9. Rheolytic Thrombectomy Market Segmentation
10. Rheolytic Thrombectomy Market Regional And Country Analysis
11. Asia-Pacific Rheolytic Thrombectomy Market
12. China Rheolytic Thrombectomy Market
13. India Rheolytic Thrombectomy Market
14. Japan Rheolytic Thrombectomy Market
15. Australia Rheolytic Thrombectomy Market
16. Indonesia Rheolytic Thrombectomy Market
17. South Korea Rheolytic Thrombectomy Market
18. Taiwan Rheolytic Thrombectomy Market
19. South East Asia Rheolytic Thrombectomy Market
20. Western Europe Rheolytic Thrombectomy Market
21. UK Rheolytic Thrombectomy Market
22. Germany Rheolytic Thrombectomy Market
23. France Rheolytic Thrombectomy Market
24. Italy Rheolytic Thrombectomy Market
25. Spain Rheolytic Thrombectomy Market
26. Eastern Europe Rheolytic Thrombectomy Market
27. Russia Rheolytic Thrombectomy Market
28. North America Rheolytic Thrombectomy Market
29. USA Rheolytic Thrombectomy Market
30. Canada Rheolytic Thrombectomy Market
31. South America Rheolytic Thrombectomy Market
32. Brazil Rheolytic Thrombectomy Market
33. Middle East Rheolytic Thrombectomy Market
34. Africa Rheolytic Thrombectomy Market
36. Rheolytic Thrombectomy Market Competitive Landscape And Company Profiles
37. Rheolytic Thrombectomy Market Other Major And Innovative Companies
41. Rheolytic Thrombectomy Market High Potential Countries, Segments and Strategies
42. Appendix
Executive Summary
Rheolytic Thrombectomy Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses rheolytic thrombectomy market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for rheolytic thrombectomy? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The rheolytic thrombectomy market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Product Type: Rheolytic Thrombectomy Devices; Aspiration Thrombectomy Devices; Mechanical Thrombectomy Devices; Ultrasonic Thrombectomy Devices2) By Procedure Type: Acute Limb Ischemia; Chronic Limb Ischemia; Coronary Thrombectomy; Pulmonary Embolism
3) By Patient Demographics: Adults; Geriatrics; Pediatrics
4) By Application: Cardiovascular Applications; Peripheral Vascular Applications; Neurovascular Applications; Pulmonary Embolism Applications
5) By End User: Hospitals; Ambulatory Surgical Centers; Specialized Clinics; Research Institutions
Subsegments:
1) By Rheolytic Thrombectomy Devices: High Pressure Saline Jet Devices; Catheter Based Rheolytic Devices; Angled Tip Rheolytic Devices; Multi Lumen Rheolytic Systems2) By Aspiration Thrombectomy Devices: Manual Aspiration Devices; Vacuum Assisted Aspiration Devices; Continuous Aspiration Systems; Large Bore Aspiration Catheters
3) By Mechanical Thrombectomy Devices: Rotational Thrombectomy Devices; Fragmentation Thrombectomy Devices; Basket Retrieval Devices; Clot Maceration Systems
4) By Ultrasonic Thrombectomy Devices: Ultrasound Assisted Catheter Devices; High Frequency Ultrasonic Systems; Acoustic Pulse Thrombectomy Devices; Combined Ultrasonic Aspiration Devices
Companies Mentioned: Johnson & Johnson; Abbott Laboratories; Medtronic plc; Koninklijke Philips N.V.; Stryker Corporation; Becton Dickinson and Company; Boston Scientific Corporation; Terumo Corporation; Edwards Lifesciences; Teleflex Incorporated; Penumbra Inc.; Inari Medical Inc.; AngioDynamics Inc.; Surmodics Inc.; LeMaitre Vascular Inc.; Imperative Care Inc.; Argon Medical Devices Inc.; Acandis GmbH & Co. KG; Vesalio LLC
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
- Johnson & Johnson
- Abbott Laboratories
- Medtronic plc
- Koninklijke Philips N.V.
- Stryker Corporation
- Becton Dickinson and Company
- Boston Scientific Corporation
- Terumo Corporation
- Edwards Lifesciences
- Teleflex Incorporated
- Penumbra Inc.
- Inari Medical Inc.
- AngioDynamics Inc.
- Surmodics Inc.
- LeMaitre Vascular Inc.
- Imperative Care Inc.
- Argon Medical Devices Inc.
- Acandis GmbH & Co. KG
- Vesalio LLC
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | July 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 1.26 Billion |
| Forecasted Market Value ( USD | $ 1.9 Billion |
| Compound Annual Growth Rate | 10.9% |
| Regions Covered | Global |
| No. of Companies Mentioned | 19 |
